A multi-center, randomized, double-blind, parallel, two-group phase III trial on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in first-line treatment of non-squamous non-small cell lung cancer
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 8016-8016
◽
Keyword(s):
2007 ◽
Vol 5
(4)
◽
pp. 356
◽
Keyword(s):
2012 ◽
Vol 7
(9)
◽
pp. 1432-1439
◽
Keyword(s):
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 8017-8017
◽
Keyword(s):
Keyword(s):